Wave Life Sciences Financials - Benzinga

Wave Life Sciences Inc

WVENASDAQ

Trade with Public

Trade with Public

$3.85

-0.11-2.78%

À la clôture: Sep 25, 5:00 PM EST

$3.85

-0.11-2.78%

Après les heures: 4:05 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Wave Life Sciences Financials

Wave Life Sciences (WVE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 9.68 percent decrease over losses of $(0.31) per share

Benzinga Newsdesk

PRO
Wave Life Sciences Reports Cash And Cash Equivalents Of $544.6M As Of March 31, 2026, With Expected Cash Runway into Q3 2028

Benzinga Newsdesk

PRO
WAVE Life Sciences Q1 EPS $(0.13) Beats $(0.33) Estimate, Sales $38.246M May Not Be Comparable To $9.119M Estimate

Benzinga Newsdesk

Earnings Scheduled For April 28, 2026

Benzinga Insights

Earnings Summary: WAVE Life Sciences Q4

Benzinga Insights

PRO
WAVE Life Sciences Reported Cash And Cash Equivalents Of $602.1M As Of December 31, 2025 And Expected Cash Runway Into Q3 2028

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved